Under the normal conditions, NF-κB binds to the inhibitor IκBα with the inactivated form in the cytoplasm; however, under the tumor environment, the degradation of IκBα leads to the transfer of NF-κB into the nucleus [62]. The gene discussed is NFKBIA; the disease is neoplasm.